LFTD Partners Inc.

LIFD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $1.8M $2.1M $4.4M $3.5M $1.6M $439.1K $4.4M $4.4M
Accounts Receivable $2.5M $2.7M $3.6M $2.4M $3.5M $1.4M $0 —
Inventory $11.0M $9.3M $10.2M $6.0M $3.8M $641.2K $0 —
Total Current Assets $15.7M $17.2M $21.7M $13.9M $13.2M $3.3M $4.6M $0
Property, Plant & Equipment $2.3M $2.7M $3.0M $1.0M $433.2K $135.4K $0 —
Goodwill $0 $23.1M $23.1M $22.3M $22.3M $22.3M $0 —
Intangible Assets (Excl. Goodwill) — — — $0 $1.4K $3.1K — —
Total Assets $19.3M $47.6M $51.3M $41.1M $39.4M $27.8M $6.5M $0
Liabilities
Accounts Payable $3.3M $4.9M $6.2M $4.0M $4.7M $639.5K $38.5K $113.5K
Total Current Liabilities $5.2M $6.4M $8.7M $6.2M $11.9M $2.3M $189.2K $338.6K
Long-Term Debt — — — — — — — —
Total Liabilities $6.6M $10.1M $12.5M $6.6M $12.0M $6.2M $189.2K $338.6K
Stockholders' Equity
Retained Earnings $-28.8M $-4.0M $-2.1M $-4.2M $-11.4M $-17.1M $-15.4M $-14.0M
Total Stockholders' Equity $12.6M $37.5M $38.8M $34.5M $27.5M $21.6M $6.3M $-338.6K
← Newer Page 1 of 2 Older →